Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Bonnetain

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
BMC Cancer|July 5, 2015
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancerBenoist Chibaudel, Franck Bonnetain, Christophe Tournigand, et al.
The Journal of Pathology|March 26, 2011
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survivalSylvain Ladoire, Grégoire Mignot, Sandrine Dabakuyo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2015
Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation aloneJulie Vincent, Christophe Mariette, Denis Pezet, et al.
JAMA|May 4, 2016
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical TrialPascal Hammel, Florence Huguet, Jean-Luc van Laethem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102Laurent Bedenne, Pierre Michel, Olivier Bouché, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2011
Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinomaMathieu Boulin, Anne Ciboulet, Boris Guiu, et al.
BMC Gastroenterology|August 14, 2014
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapyFrédéric Fiteni, Marine Jary, Franck Monnien, et al.
Health and Quality of Life Outcomes|June 3, 2014
Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 studyMomar Diouf, Benoist Chibaudel, Thomas Filleron, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre studyBertrand Brieau, Claire Auzolle, Astrid Pozet, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2015
Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinomaMarine Jary, Dewi Vernerey, Thierry Lecomte, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
BMC Cancer|July 5, 2015
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancerBenoist Chibaudel, Franck Bonnetain, Christophe Tournigand, et al.
The Journal of Pathology|March 26, 2011
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survivalSylvain Ladoire, Grégoire Mignot, Sandrine Dabakuyo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2015
Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation aloneJulie Vincent, Christophe Mariette, Denis Pezet, et al.
JAMA|May 4, 2016
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical TrialPascal Hammel, Florence Huguet, Jean-Luc van Laethem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102Laurent Bedenne, Pierre Michel, Olivier Bouché, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2011
Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinomaMathieu Boulin, Anne Ciboulet, Boris Guiu, et al.
BMC Gastroenterology|August 14, 2014
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapyFrédéric Fiteni, Marine Jary, Franck Monnien, et al.
Health and Quality of Life Outcomes|June 3, 2014
Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 studyMomar Diouf, Benoist Chibaudel, Thomas Filleron, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre studyBertrand Brieau, Claire Auzolle, Astrid Pozet, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2015
Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinomaMarine Jary, Dewi Vernerey, Thierry Lecomte, et al.
Pageof 17